COVID-19 and HIV co-infection: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 12: | Line 12: | ||
==Overview== | ==Overview== | ||
*An observational prospective study found out that the incidence of HIV-infected individuals to be affected by SARS-CoV-2 was similar to the general population. | |||
*Specific antiretroviral therapy did not affect COVID-19 severity. | |||
*[[Immunosuppression]](low CD4 cell counts) was associated with COVID-19 severity. | |||
*Patients with HIV infection often have other comorbidities(lung disease, cardiovascular disease) therefore, increasing the risk for severe-COVID-19 disease. | |||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 17:49, 10 July 2020
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19 and HIV co-infection On the Web |
|
American Roentgen Ray Society Images of COVID-19 and HIV co-infection |
|
Risk calculators and risk factors for COVID-19 and HIV co-infection |
For COVID-19 frequently asked inpatient questions, click here
For COVID-19 frequently asked outpatient questions, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Harmeet Kharoud M.D.[2]
Synonyms and keywords:
Overview
- An observational prospective study found out that the incidence of HIV-infected individuals to be affected by SARS-CoV-2 was similar to the general population.
- Specific antiretroviral therapy did not affect COVID-19 severity.
- Immunosuppression(low CD4 cell counts) was associated with COVID-19 severity.
- Patients with HIV infection often have other comorbidities(lung disease, cardiovascular disease) therefore, increasing the risk for severe-COVID-19 disease.